Skip to main content

Table 5 Percent of private sector outlets who reportedly received government or non-governmental support, and among outlets who received a support strategy, type of support received

From: Evidence on anti-malarial and diagnostic markets in Cambodia to guide malaria elimination strategies and policies

  Private for-profit health facility Pharmacy Drug store General retailer Itinerant drug vendor All private sector
% (95% CI) % (95% CI) % (95% CI) % (95% CI) % (95% CI) % (95% CI)
  N = 326 N = 99 N = 46 N = 39 N = 235 N = 745
Received any type of support 60.2 (53.6, 66.4) 71.7 (61.7, 80.0) 45.5 (29.7, 62.2) 3.2 (0.7, 13.8) 25.5 (18.8, 33.6) 44.4 (39.0, 49.9)
Among outlets with support N = 196 N = 69 N = 19 N = 1 N = 64 N = 349
 Report access to subsidized anti-malarials 58.3 (49.2, 66.9) 69.4 (58.7, 78.5) 26.8 (13.3, 46.6) 0.0 (–) 55.7 (44.4, 66.5) 57.5 (51.1, 63.7)
 Report access to subsidized RDT 63.5 (54.0, 72.1) 69.1 (58.9, 77.7) 60.2 (36.4, 80.0) 0.0 (–) 58.6 (45.5, 70.7) 63.0 (55.9, 69.6)
 Report received training in the past year on malaria diagnosis (RDT and/or microscopy) and/or the National treatment guidelines for malaria 65.3 (57.1, 72.7) 66.0 (53.2, 76.8) 36.1 (18.0, 59.2) 100.0 (–) 42.6 (31.5, 54.4) 59.1 (53.9, 64.2)
 Report receiving a supervisory or regulatory visit within the past year 27.6 (21.7, 34.3) 17.8 (8.9, 32.6) 20.7 (5.5, 54.0) 0.0 (–) 8.6 (3.9, 18.0) 21.4 (16.7, 27.0)
 Report keeping and reporting malaria caseload data to government or non-government organization 50.3 (40.0, 60.6) 22.2 (11.8, 37.9) 18.0 (4.0, 53.4) 0.0 (–) 21.1 (11.7, 35.0) 36.9 (27.8, 47.1)